Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 15 tags : Disease save search
Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Meeting 2021, the Annual Meeting of the American Association for the Study of Liver Diseases
Published: 2021-11-15 (Crawled : 20:00) - biospace.com/
SRZN 4 | $9.75 -9.13% -2.38% 18K
|
|
| O: -3.37%
H: 6.98%
C: 3.6%
disease liver disease potential liver
Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases
Published: 2021-11-15 (Crawled : 15:00) - biospace.com/
TWST | $29.24 -4.69% -4.96% 860K
|
Health Technology
|
| O: -0.39%
H: 1.4%
C: -4.96%
covid disease antibody iot
Kala Pharmaceuticals Acquires Combangio, Expanding its Pipeline with a Clinical-Stage Novel Biologic for the Treatment of Persistent Corneal Epithelial Defect (PCED) and other Rare Ocular Surface Diseases
Published: 2021-11-15 (Crawled : 14:00) - globenewswire.com
KALA | $7.0 -2.78% 1.1% 24K
|
Health Technology
|
| O: -0.97%
H: 11.22%
C: 2.44%
disease treatment ocular rare
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
RCKT S | $24.01 -0.74% -0.75% 580K
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: -23.94%
disease phase 1 positive trial phase 2 phase 3 rp-a501 danon disease
Trevi Therapeutics to Present at 5th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases
Published: 2021-11-15 (Crawled : 12:30) - prnewswire.com
TRVI | $2.81 -3.77% -5.04% 57K
|
Health Technology
|
| O: -1.68%
H: 0.85%
C: -5.98%
disease drug skin
Viridian Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for VRDN-001, an IGF-1R Antibody for the Treatment of Thyroid Eye Disease (TED)
Published: 2021-11-15 (Crawled : 12:00) - globenewswire.com
VRDN | $15.64 -1.57% -1.47% 880K
|
Health Care and Social Assistan...
|
| O: 3.83%
H: 0.0%
C: -0.67%
new drug disease fda clearance treatment fda eye application eye disease antibody drug clearance
Gainers vs Losers
| 45% | 55% |
Top 10 Gainers
DYNT | $0.3704 -5.27% 43.09% 5.5M
|
Health Technology
BRTX | $1.32 -1.49% 20.71% 3.3M
|
Professional, Scientific, and T...
PTN | $1.82 -5.21% 15.38% 290K
|
Health Technology
VIAO | $0.308 -26.67% 12.01% 390K
|
Electronic Technology
HNRA | $2.36 -9.58% 11.86% 220K
|
n/a
HYLN 4 | $1.32 -7.04% 8.33% 800K
|
Producer Manufacturing
UMAC | $1.85 -2.12% 8.11% 6.1K
|
BQ | $0.2429 -6.07% 6.63% 99K
|
Consumer Non-Durables
GORO F | $0.534 -0.6% 6.55% 630K
|
Non-Energy Minerals
LBRT 4 | $22.1 -1.6% 6.29% 2.1M
|
Industrial Services
Your saved searches
Save your searches and get alerts when important news are released.